{"transactions":[{"id":3581874,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":158890,"kind":"person","name":"Duliege Anne-Marie","position":1,"cik":"0001419579","reported_name":"Duliege Anne-Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-03-22T23:19:52.000Z","date":"2019-03-20","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 24, 2018, the reporting person was granted a performance based option to purchase 75,000 shares of common stock based on a specific performance metric. On March 20, 2019, it was determined that the performance metric had been met."}],"balance_after":75000,"derivative":{"exercise_price":4.49,"expiration_date":"2028-01-24","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001179110-19-004206","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911019004206/edgar.xml","form_type":"4"}},{"id":3686935,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":158890,"kind":"person","name":"Duliege Anne-Marie","position":1,"cik":"0001419579","reported_name":"Duliege Anne-Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-25T23:23:49.000Z","date":"2019-01-23","kind":"grant","acquired":true,"shares":162500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2019."}],"balance_after":162500,"derivative":{"exercise_price":2,"expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":162500},"source":{"system":"sec-edgar","filing":"0001179110-19-000933","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911019000933/edgar.xml","form_type":"4"}},{"id":3811918,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":158890,"kind":"person","name":"Duliege Anne-Marie","position":1,"cik":"0001419579","reported_name":"Duliege Anne-Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-09-19T22:26:06.000Z","date":"2018-09-17","kind":"exercise","acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares vest over four (4) years from January 1, 2017."}],"balance_after":112500,"derivative":{"exercise_price":2.11,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001179110-18-011567","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911018011567/edgar.xml","form_type":"4"}},{"id":3811917,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":158890,"kind":"person","name":"Duliege Anne-Marie","position":1,"cik":"0001419579","reported_name":"Duliege Anne-Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Employe Stock Option (right to buy)","published_at":"2018-09-19T22:26:06.000Z","date":"2018-09-17","kind":"exercise","acquired":false,"shares":115500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One fourth (1/4th) of the option vests one (1) year from March 7, 2016 and thereafter the balance of the option vests in equal monthly installments over the next thirty-six (36) months."}],"balance_after":268000,"derivative":{"exercise_price":2.54,"expiration_date":"2026-05-05","underlying":"Common Stock","underlying_shares":115500},"source":{"system":"sec-edgar","filing":"0001179110-18-011567","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911018011567/edgar.xml","form_type":"4"}},{"id":3811916,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":158890,"kind":"person","name":"Duliege Anne-Marie","position":1,"cik":"0001419579","reported_name":"Duliege Anne-Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-19T22:26:06.000Z","date":"2018-09-17","kind":"sale","acquired":false,"shares":37500,"price":3.5,"value":131250.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2018."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-011567","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911018011567/edgar.xml","form_type":"4"}},{"id":3811915,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":158890,"kind":"person","name":"Duliege Anne-Marie","position":1,"cik":"0001419579","reported_name":"Duliege Anne-Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-19T22:26:06.000Z","date":"2018-09-17","kind":"exercise","acquired":true,"shares":37500,"price":2.11,"value":79125.0,"ownership":{"direct":true},"balance_after":37500,"source":{"system":"sec-edgar","filing":"0001179110-18-011567","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911018011567/edgar.xml","form_type":"4"}},{"id":3811914,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":158890,"kind":"person","name":"Duliege Anne-Marie","position":1,"cik":"0001419579","reported_name":"Duliege Anne-Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-19T22:26:06.000Z","date":"2018-09-17","kind":"sale","acquired":false,"shares":115500,"price":3.5,"value":404250.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2018."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-011567","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911018011567/edgar.xml","form_type":"4"}},{"id":3811913,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":158890,"kind":"person","name":"Duliege Anne-Marie","position":1,"cik":"0001419579","reported_name":"Duliege Anne-Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-19T22:26:06.000Z","date":"2018-09-17","kind":"exercise","acquired":true,"shares":115500,"price":2.54,"value":293370.0,"ownership":{"direct":true},"balance_after":115500,"source":{"system":"sec-edgar","filing":"0001179110-18-011567","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911018011567/edgar.xml","form_type":"4"}},{"id":3823898,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":158890,"kind":"person","name":"Duliege Anne-Marie","position":1,"cik":"0001419579","reported_name":"Duliege Anne-Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Employe Stock Option (right to buy)","published_at":"2018-09-06T23:02:37.000Z","date":"2018-09-04","kind":"exercise","acquired":false,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One fourth (1/4th) of the option vests one (1) year from March 7, 2016 and thereafter the balance of the option vests in equal monthly installments over the next thirty-six (36) months."}],"balance_after":383500,"derivative":{"exercise_price":2.54,"expiration_date":"2026-05-05","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001179110-18-011179","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911018011179/edgar.xml","form_type":"4"}},{"id":3823897,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":158890,"kind":"person","name":"Duliege Anne-Marie","position":1,"cik":"0001419579","reported_name":"Duliege Anne-Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-06T23:02:37.000Z","date":"2018-09-04","kind":"sale","acquired":false,"shares":16500,"price":3.5067,"value":57860.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is the weighted average price.  These shares were sold in multiple transactions ranging from $3.50 to $3.53.  Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission full information regarding the shares sold at each such separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-011179","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911018011179/edgar.xml","form_type":"4"}},{"id":3823896,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":158890,"kind":"person","name":"Duliege Anne-Marie","position":1,"cik":"0001419579","reported_name":"Duliege Anne-Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-06T23:02:37.000Z","date":"2018-09-04","kind":"exercise","acquired":true,"shares":16500,"price":2.54,"value":41910.0,"ownership":{"direct":true},"balance_after":16500,"source":{"system":"sec-edgar","filing":"0001179110-18-011179","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911018011179/edgar.xml","form_type":"4"}},{"id":3873043,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":158890,"kind":"person","name":"Duliege Anne-Marie","position":1,"cik":"0001419579","reported_name":"Duliege Anne-Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-07-05T22:59:19.000Z","date":"2018-07-02","kind":"sale","acquired":false,"shares":5000,"price":2.7864,"value":13932.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26,2018."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person purchased these shares on June 29, 2018 under the Issuer's Employee Stock Purchase Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is the weighted average price.  These shares were sold in multiple transactions ranging from $2.76 to $2.80.  Upon request, the reporting person undertakes to provide the Issuer, any security holder of the issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each such separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-009506","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911018009506/edgar.xml","form_type":"4"}},{"id":3937325,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":158890,"kind":"person","name":"Duliege Anne-Marie","position":1,"cik":"0001419579","reported_name":"Duliege Anne-Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-05-11T23:33:39.000Z","date":"2018-05-09","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 2, 2017 the reporting person was granted an option to purchase 150,000 shares of common stock.  The option vested based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved.  On May 9, 2018, the Compensation Committee determined that the performance conditions had been achieved, resulting in full vesting of the option."}],"balance_after":150000,"derivative":{"exercise_price":2.11,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001179110-18-006678","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911018006678/edgar.xml","form_type":"4"}},{"id":3958120,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":158890,"kind":"person","name":"Duliege Anne-Marie","position":1,"cik":"0001419579","reported_name":"Duliege Anne-Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-25T01:06:22.000Z","date":"2018-04-20","kind":"sale","acquired":false,"shares":5000,"price":4.11,"value":20550.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2018."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person purchased these shares on December 29, 2017 under the Employee Stock Purchase Plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-18-005850","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911018005850/edgar.xml","form_type":"4"}},{"id":4088431,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":158890,"kind":"person","name":"Duliege Anne-Marie","position":1,"cik":"0001419579","reported_name":"Duliege Anne-Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-01-26T23:30:43.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2018."}],"balance_after":150000,"derivative":{"exercise_price":4.49,"expiration_date":"2028-01-24","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001179110-18-001142","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911018001142/edgar.xml","form_type":"4"}},{"id":4261074,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":158890,"kind":"person","name":"Duliege Anne-Marie","position":1,"cik":"0001419579","reported_name":"Duliege Anne-Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-07-07T21:39:13.000Z","date":"2017-07-05","kind":"sale","acquired":false,"shares":5000,"price":2.6854,"value":13427.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 10, 2016."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person purchased these shares on 6/30/17 under the Employee Stock Purchase Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $2.65 to $2.75, inclusive.  Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price within the range set forth in footnote three (3) of this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-17-010231","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911017010231/edgar.xml","form_type":"4"}},{"id":4466630,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":158890,"kind":"person","name":"Duliege Anne-Marie","position":1,"cik":"0001419579","reported_name":"Duliege Anne-Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-07T00:25:44.000Z","date":"2017-02-02","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest monthly over four (4) years from January 1, 2017."}],"balance_after":150000,"derivative":{"exercise_price":2.11,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001179110-17-001818","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911017001818/edgar.xml","form_type":"4"}},{"id":4491288,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":158890,"kind":"person","name":"Duliege Anne-Marie","position":1,"cik":"0001419579","reported_name":"Duliege Anne-Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-01-13T23:02:21.000Z","date":"2017-01-03","kind":"sale","acquired":false,"shares":5000,"price":2.4055,"value":12027.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2016"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.36 to $2.44, inclusive. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price within the ranges set forth in footnote three (3) of this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-17-000942","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911017000942/edgar.xml","form_type":"4"}}]}